Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2408380
Max Phase: Preclinical
Molecular Formula: C38H30ClNO10
Molecular Weight: 696.11
Molecule Type: Small molecule
Associated Items:
ID: ALA2408380
Max Phase: Preclinical
Molecular Formula: C38H30ClNO10
Molecular Weight: 696.11
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCOC(=O)c1cn([C@@H]2O[C@H](COC(=O)c3ccccc3)[C@@H](OC(=O)c3ccccc3)[C@H]2OC(=O)c2ccccc2)c2ccc(Cl)cc2c1=O
Standard InChI: InChI=1S/C38H30ClNO10/c1-2-46-38(45)28-21-40(29-19-18-26(39)20-27(29)31(28)41)34-33(50-37(44)25-16-10-5-11-17-25)32(49-36(43)24-14-8-4-9-15-24)30(48-34)22-47-35(42)23-12-6-3-7-13-23/h3-21,30,32-34H,2,22H2,1H3/t30-,32-,33-,34-/m1/s1
Standard InChI Key: MWSOQJFJGWOXEU-DWNQJFHRSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 696.11 | Molecular Weight (Monoisotopic): 695.1558 | AlogP: 6.04 | #Rotatable Bonds: 10 |
Polar Surface Area: 136.43 | Molecular Species: NEUTRAL | HBA: 11 | HBD: 0 |
#RO5 Violations: 3 | HBA (Lipinski): 11 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: 8.42 | CX LogD: 8.42 |
Aromatic Rings: 5 | Heavy Atoms: 50 | QED Weighted: 0.13 | Np Likeness Score: 0.11 |
1. Leitão A, Andricopulo AD, Oliva G, Pupo MT, de Marchi AA, Vieira PC, da Silva MF, Ferreira VF, de Souza MC, Sá MM, Moraes VR, Montanari CA.. (2004) Structure-activity relationships of novel inhibitors of glyceraldehyde-3-phosphate dehydrogenase., 14 (9): [PMID:15081008] [10.1016/j.bmcl.2004.02.025] |
2. Soares FA, Sesti-Costa R, da Silva JS, de Souza MC, Ferreira VF, Santos Fda C, Monteiro PA, Leitão A, Montanari CA.. (2013) Molecular design, synthesis and biological evaluation of 1,4-dihydro-4-oxoquinoline ribonucleosides as TcGAPDH inhibitors with trypanocidal activity., 23 (16): [PMID:23850203] [10.1016/j.bmcl.2013.06.029] |
Source(1):